Global harmonization of CGT regulations could expedite access to innovative therapies by standardizing evaluation and regulatory processes. Only 20% of trials submitted to both the FDA and EMA had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback